[go: up one dir, main page]

DK1429770T3 - Nye formuleringer og anvendelse deraf - Google Patents

Nye formuleringer og anvendelse deraf

Info

Publication number
DK1429770T3
DK1429770T3 DK02799531T DK02799531T DK1429770T3 DK 1429770 T3 DK1429770 T3 DK 1429770T3 DK 02799531 T DK02799531 T DK 02799531T DK 02799531 T DK02799531 T DK 02799531T DK 1429770 T3 DK1429770 T3 DK 1429770T3
Authority
DK
Denmark
Prior art keywords
new formulations
formulations
new
Prior art date
Application number
DK02799531T
Other languages
English (en)
Inventor
Tomas Landh
Nils-Olof Lindberg
Original Assignee
Mcneil Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ab filed Critical Mcneil Ab
Application granted granted Critical
Publication of DK1429770T3 publication Critical patent/DK1429770T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/42—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G1/426—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins or antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK02799531T 2001-09-27 2002-09-10 Nye formuleringer og anvendelse deraf DK1429770T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0103210A SE0103210D0 (sv) 2001-09-27 2001-09-27 New formulations and use thereof
PCT/SE2002/001612 WO2003026656A1 (en) 2001-09-27 2002-09-10 New formulations and use thereof

Publications (1)

Publication Number Publication Date
DK1429770T3 true DK1429770T3 (da) 2009-08-03

Family

ID=20285456

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02799531T DK1429770T3 (da) 2001-09-27 2002-09-10 Nye formuleringer og anvendelse deraf

Country Status (19)

Country Link
EP (1) EP1429770B1 (da)
JP (1) JP4262094B2 (da)
KR (1) KR20040047868A (da)
CN (1) CN1561213A (da)
AR (1) AR036679A1 (da)
AT (1) ATE431144T1 (da)
AU (1) AU2002334523B2 (da)
BR (1) BR0212834A (da)
CA (1) CA2461757C (da)
DE (1) DE60232344D1 (da)
DK (1) DK1429770T3 (da)
ES (1) ES2325684T3 (da)
IL (1) IL160886A0 (da)
MX (1) MXPA04002876A (da)
NZ (1) NZ532528A (da)
RU (1) RU2282447C2 (da)
SE (1) SE0103210D0 (da)
WO (1) WO2003026656A1 (da)
ZA (1) ZA200402091B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767698B2 (en) 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8469036B2 (en) 2003-11-07 2013-06-25 U.S. Smokeless Tobacco Company Llc Tobacco compositions
RU2320674C1 (ru) * 2006-07-12 2008-03-27 Каш Тенгис Способ получения сополимера n-винилпирролидона с лаурилметакрилатом для трансдермального введения никотина, сополимер, полученный этим способом, гель для трансдермального введения никотина
CZ200980A3 (cs) * 2009-02-11 2010-04-28 Heglund A.S. Kompozice urcená k bukální absorpci nikotinu za úcelem odvykání kourení
RU2448573C1 (ru) * 2010-12-27 2012-04-27 Олег Иванович Квасенков Способ получения некурительного изделия из махорки
RU2453754C1 (ru) * 2010-12-27 2012-06-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования Сибирский федеральный университет (СФУ) Устройство для бестраншейной замены трубопроводов

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8404808L (sv) * 1983-10-03 1985-04-04 Avner Rotman Mikrokapslat lekemedel i sot matris
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
SE9803986D0 (sv) * 1998-11-23 1998-11-23 Pharmacia & Upjohn Ab New compositions
SE0103211D0 (sv) * 2001-09-27 2001-09-27 Pharmacia Ab New formulations and use thereof

Also Published As

Publication number Publication date
MXPA04002876A (es) 2005-06-20
EP1429770A1 (en) 2004-06-23
ATE431144T1 (de) 2009-05-15
RU2004108853A (ru) 2005-04-20
EP1429770B1 (en) 2009-05-13
CA2461757A1 (en) 2003-04-03
AU2002334523B2 (en) 2007-02-15
CA2461757C (en) 2008-09-02
NZ532528A (en) 2005-10-28
SE0103210D0 (sv) 2001-09-27
ZA200402091B (en) 2005-06-29
CN1561213A (zh) 2005-01-05
KR20040047868A (ko) 2004-06-05
RU2282447C2 (ru) 2006-08-27
JP2005503429A (ja) 2005-02-03
ES2325684T3 (es) 2009-09-14
DE60232344D1 (de) 2009-06-25
IL160886A0 (en) 2004-08-31
BR0212834A (pt) 2004-10-13
JP4262094B2 (ja) 2009-05-13
WO2003026656A1 (en) 2003-04-03
AR036679A1 (es) 2004-09-29

Similar Documents

Publication Publication Date Title
DK1429769T3 (da) Nye formuleringer og anvendelse deraf
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
IS6934A (is) Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar
DK1370128T3 (da) Kombineret ballepresse og ballevikler
EP1298180A4 (en) HYDROPHOBIC AND LIPOPHOBE COMPOSITION
NO20022289D0 (no) Ny anvendelse og nye N-azabisykloamidderivater
DK1455785T3 (da) Substituerede 2-thio-3,5-dicyano-4-phenyl-6-aminopyridiner og deres anvendelse
IS7040A (is) 5-HT viðtakabindlar og notkun þeirra
NO20033456D0 (no) Modifiserte og stabiliserte GDF-propeptider og anvendelse derav
DK1122244T3 (da) Uracilforbindelser og anvendelse deraf
NO20042229L (no) Type 4-fosfodiestemseinhibitorer og anvendelse derav
DK1268425T3 (da) Carbamatcaspaseinhibitorer og anvendelse deraf
NO20031744L (no) Nye ikke-imadazolforbindelser og farmasöytisk preparat omfattende slike
IS8074A (is) Setin 1,4- Díazepín og notkun theirra
NO20041272L (no) Tetracycline derivatives and methods of use thereof
NO20034159L (no) Östrogen-gestagen-kombinasjonspreparat og anvendelse derav
NO20033854D0 (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
IS2482B (is) Arómatísk súlfón og læknisfræðileg notkun þeirra
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
EP1351388A4 (en) PHASE SLIDER AND MULTIBIT PHASE SLIDER
NO20035332D0 (no) Nye heterocykliske derivater og medisinsk anvendelse derav
NO20042693L (no) Kateterpreparat og anvendelser derav
NO20030822L (no) Nye forbindelser og fremgangsmåter
NO20030156D0 (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
NO20044106L (no) Omkonstruerte baculoviruser og anvendelse derav